Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment Service

被引:0
|
作者
Gupta-Wright, Ankur [1 ]
Wood, Robin [2 ]
Bekker, Linda-Gail [2 ]
Lawn, Stephen D. [1 ,2 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1E 7HT, England
[2] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
基金
美国国家卫生研究院; 英国惠康基金;
关键词
tuberculosis; HIV; viral load; virological failure; antiretroviral; Africa; HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; RISK-FACTORS; VIRAL LOAD; TREATMENT PROGRAMS; DRUG-RESISTANCE; THERAPY; EFAVIRENZ; MORTALITY; FAILURE;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The temporal relationship between incident tuberculosis (TB) and virological outcomes during antiretroviral therapy (ART) is poorly defined. This was studied in a cohort in Cape Town, South Africa. Methods: Data regarding TB diagnoses, ART regimens, and 4-monthly updated viral load (VL) and CD4 count measurements were extracted from a prospectively maintained database. Rates of virological breakthrough (VL > 1000 copies/mL) and failure (VL > 1000 copies/mL on serial measurements) following initial VL suppression were calculated. Poisson models were used to calculate incidence rate ratios (IRRs) and identify risk factors for these virological outcomes. Results: Incident TB was diagnosed in 391 (28.5%) of 1370 patients during a median of 5.2 years follow-up. Five hundred seventy-eight episodes of virological breakthrough and 231 episodes of virological failure occurred, giving rates of 10.0 episodes per 100 person-years and 4.0 episodes per 100 person-years, respectively. In multivariate analyses adjusted for baseline and time-updated risk factors, TB was an independent risk factor for adverse virological outcomes. These associations were strongly time dependent; the 6-month period following diagnosis of incident TB was associated with a substantially increased risk of virological breakthrough (IRR: 2.3, 95% confidence interval: 1.7 to 3.2) and failure (IRR: 2.6, 95% confidence interval: 1.6 to 4.3) compared with time without a TB diagnosis. Person-time preceding TB diagnosis or more than 6 months after a TB diagnosis was not associated with poor virological outcomes. Conclusions: Incident TB during ART was strongly associated with poor virological outcomes during the 6-month period following TB diagnosis. Although underlying mechanisms remain to be defined, patients with incident TB may benefit from virological monitoring and treatment adherence support.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 46 条
  • [1] Outcomes Following Virological Failure and Predictors of Switching to Second-line Antiretroviral Therapy in a South African Treatment Program
    Johnston, Victoria
    Fielding, Katherine L.
    Charalambous, Salome
    Churchyard, Gavin
    Phillips, Andrew
    Grant, Alison D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (03) : 370 - 380
  • [2] Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia
    Miyano, S.
    Dube, C.
    Kayama, N.
    Ishikawa, N.
    Nozaki, I.
    Syakantu, G.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (04) : 540 - 545
  • [3] Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS
    Yen, Yung-Feng
    Jen, I-An
    Chuang, Pei-Hung
    Chen, Marcelo
    Lan, Yu-Ching
    Lee, Chun-Yuan
    Chen, Yi-Ming Arthur
    ANNALS OF EPIDEMIOLOGY, 2018, 28 (12) : 886 - 892
  • [4] Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa
    Nglazi, Mweete D.
    Lawn, Stephen D.
    Kaplan, Richard
    Kranzer, Katharina
    Orrell, Catherine
    Wood, Robin
    Bekker, Linda-Gail
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (01) : E1 - E8
  • [5] The Effect of Tuberculosis Treatment on Virologic and Immunologic Response to Combination Antiretroviral Therapy Among South African Children
    Soeters, Heidi M.
    Sawry, Shobna
    Moultrie, Harry
    Van Rie, Annelies
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (02) : 136 - 144
  • [6] Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
    Moorhouse, Michelle
    Maartens, Gary
    Venter, Willem Daniel Francois
    Moosa, Mahomed-Yunus
    Steegen, Kim
    Jamaloodien, Khadija
    Fox, Matthew P.
    Conradie, Francesca
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (01) : 73 - 78
  • [7] Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression
    Nglazi, Mweete D.
    Kaplan, Richard
    Orrell, Catherine
    Myer, Landon
    Wood, Robin
    Bekker, Linda-Gail
    Lawn, Stephen D.
    PLOS ONE, 2013, 8 (03):
  • [8] Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment
    Middelkoop, K.
    Bekker, L-G.
    Shashkina, E.
    Kreiswirth, B.
    Wood, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (11) : 1510 - 1516
  • [9] Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa
    Kerkhoff, Andrew D.
    Longley, Nicky
    Kelly, Nicola
    Cross, Anna
    Vogt, Monica
    Wood, Robin
    Hermans, Sabine
    Lawn, Stephen D.
    Harrison, Thomas S.
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [10] Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa
    Levison, Julie H.
    Orrell, Catherine
    Losina, Elena
    Lu, Zhigang
    Freedberg, Kenneth A.
    Wood, Robin
    ANTIVIRAL THERAPY, 2011, 16 (06) : 853 - 861